- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Diabetes mellitus
- Meeting Date: November 2021
- Public Summary Document (PSD) November 2021 PBAC Meeting - (PDF 839KB)
- Public Summary Document (PSD) November 2021 PBAC Meeting - (Word 52KB)
Insulin aspart – November 2021
Insulin aspart: Injections (human analogue), catridges, 100 units per mL, 3 mL, 5; Truvelog®; Injections (human analogue), pre-filled pen, 100 units per mL, 3 mL, 5; Truvelog Solostar®
Last updated
4 March 2022
